Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	TAP1 binding	HLA-A HLA-B HLA-C TAP2	7.22e-09	10	50	4	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-A HLA-B HLA-C TAP2	7.22e-09	10	50	4	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-A HLA-B HLA-C TAP2	7.22e-09	10	50	4	GO:0046977
GeneOntologyMolecularFunction	MHC class I protein binding	HLA-A HLA-B HLA-C TAP2	1.19e-06	32	50	4	GO:0042288
GeneOntologyMolecularFunction	TAP complex binding	HLA-A HLA-B HLA-C	1.23e-06	9	50	3	GO:0062061
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-A HLA-B HLA-C	1.23e-06	9	50	3	GO:0042610
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-A HLA-B HLA-C	3.20e-06	12	50	3	GO:0030881
GeneOntologyMolecularFunction	peptide antigen binding	HLA-A HLA-B HLA-C TAP2	6.78e-06	49	50	4	GO:0042605
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-A HLA-B HLA-C	9.80e-06	17	50	3	GO:0046703
GeneOntologyMolecularFunction	MHC protein binding	HLA-A HLA-B HLA-C TAP2	1.34e-05	58	50	4	GO:0042287
GeneOntologyMolecularFunction	T cell receptor binding	HLA-A HLA-B HLA-C	1.63e-05	20	50	3	GO:0042608
GeneOntologyMolecularFunction	peptide binding	HLA-A HLA-B HLA-C TLR4 LRP1 TAP2	1.37e-04	318	50	6	GO:0042277
GeneOntologyMolecularFunction	G protein-coupled amine receptor activity	ADRA2B HTR1D CHRM1	1.47e-04	41	50	3	GO:0008227
GeneOntologyMolecularFunction	14-3-3 protein binding	HLA-A HLA-B HLA-C	1.58e-04	42	50	3	GO:0071889
GeneOntologyMolecularFunction	toxin transmembrane transporter activity	LRP6 LRP5	3.99e-04	12	50	2	GO:0019534
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	LRP1 LRP6	7.21e-04	16	50	2	GO:0005041
GeneOntologyMolecularFunction	coreceptor activity	LRP1 LRP6 LRP5	7.80e-04	72	50	3	GO:0015026
GeneOntologyMolecularFunction	Wnt receptor activity	LRP6 LRP5	8.16e-04	17	50	2	GO:0042813
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH17 DNAH7	9.16e-04	18	50	2	GO:0008569
GeneOntologyMolecularFunction	apolipoprotein binding	LRP1 LRP6	1.13e-03	20	50	2	GO:0034185
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	LRP1 LRP6	1.25e-03	21	50	2	GO:0030228
GeneOntologyMolecularFunction	antigen binding	HLA-A HLA-B HLA-C TAP2	1.30e-03	190	50	4	GO:0003823
GeneOntologyMolecularFunction	G protein-coupled serotonin receptor activity	HTR1D CHRM1	1.37e-03	22	50	2	GO:0004993
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH17 DNAH7	2.23e-03	28	50	2	GO:0051959
GeneOntologyMolecularFunction	phospholipid binding	SNX30 SNX4 SNX3 GLE1 ADGRB1 SNX29	2.37e-03	548	50	6	GO:0005543
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH17 MYO15A DNAH7	3.22e-03	118	50	3	GO:0003774
GeneOntologyMolecularFunction	Wnt-protein binding	LRP6 LRP5	3.28e-03	34	50	2	GO:0017147
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH17 DNAH7	3.87e-03	37	50	2	GO:0045505
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	GIPR ADRA2B HTR1D TLR4 ADGRB1 ADGRB3 LRP6 LRP5 CHRM1	5.88e-03	1353	50	9	GO:0004888
GeneOntologyMolecularFunction	lipopolysaccharide binding	TLR4 ADGRB1	6.44e-03	48	50	2	GO:0001530
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate binding	SNX4 SNX3	6.44e-03	48	50	2	GO:0032266
GeneOntologyMolecularFunction	protein-folding chaperone binding	HLA-A HLA-B HLA-C	7.64e-03	161	50	3	GO:0051087
GeneOntologyMolecularFunction	phosphatidylinositol binding	SNX30 SNX4 SNX3 SNX29	8.00e-03	316	50	4	GO:0035091
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent	HLA-A HLA-B HLA-C TAP2	1.95e-09	8	49	4	GO:0002485
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	HLA-A HLA-B HLA-C TAP2	6.54e-08	17	49	4	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA-A HLA-B HLA-C TAP2	6.54e-08	17	49	4	GO:0002476
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	HLA-A HLA-B HLA-C TAP2	8.39e-08	18	49	4	GO:0002428
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-C TAP2	2.41e-07	23	49	4	GO:0019885
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen	HLA-A HLA-B HLA-C TAP2	3.43e-07	25	49	4	GO:0002483
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	HLA-A HLA-B HLA-C TAP2	3.43e-07	25	49	4	GO:0002475
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous antigen	HLA-A HLA-B HLA-C TAP2	9.62e-07	32	49	4	GO:0019883
GeneOntologyBiologicalProcess	protection from natural killer cell mediated cytotoxicity	HLA-A HLA-B TAP2	1.05e-06	9	49	3	GO:0042270
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class I	HLA-A HLA-B HLA-C TAP2	2.67e-06	41	49	4	GO:0002474
GeneOntologyBiologicalProcess	positive regulation of T cell mediated cytotoxicity	HLA-A HLA-B HLA-C TAP2	2.94e-06	42	49	4	GO:0001916
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen	HLA-A HLA-B HLA-C TAP2	5.06e-06	48	49	4	GO:0002478
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA-A HLA-B HLA-C	6.90e-06	16	49	3	GO:0002486
GeneOntologyBiologicalProcess	regulation of T cell mediated cytotoxicity	HLA-A HLA-B HLA-C TAP2	7.55e-06	53	49	4	GO:0001914
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-C	1.00e-05	18	49	3	GO:0042590
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous antigen	HLA-A HLA-B HLA-C TAP2	1.09e-05	58	49	4	GO:0019884
GeneOntologyBiologicalProcess	detection of other organism	HLA-A HLA-B TLR4	2.16e-05	23	49	3	GO:0098543
GeneOntologyBiologicalProcess	T cell mediated cytotoxicity	HLA-A HLA-B HLA-C TAP2	2.30e-05	70	49	4	GO:0001913
GeneOntologyBiologicalProcess	positive regulation of T cell mediated immunity	HLA-A HLA-B HLA-C TAP2	2.86e-05	74	49	4	GO:0002711
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen	HLA-A HLA-B HLA-C TAP2	3.18e-05	76	49	4	GO:0048002
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated cytotoxicity	HLA-A HLA-B HLA-C TAP2	3.70e-05	79	49	4	GO:0001912
GeneOntologyBiologicalProcess	Norrin signaling pathway	LRP6 LRP5	5.50e-05	5	49	2	GO:0110135
GeneOntologyBiologicalProcess	positive regulation of cell killing	HLA-A HLA-B HLA-C TAP2	5.66e-05	88	49	4	GO:0031343
GeneOntologyBiologicalProcess	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	GIPR ADRA2B HTR1D ADGRB1 ADGRB3 CHRM1	5.72e-05	286	49	6	GO:0007188
GeneOntologyBiologicalProcess	detection of external biotic stimulus	HLA-A HLA-B TLR4	6.54e-05	33	49	3	GO:0098581
GeneOntologyBiologicalProcess	establishment of blood-retinal barrier	LRP6 LRP5	8.24e-05	6	49	2	GO:1990963
GeneOntologyBiologicalProcess	regulation of leukocyte mediated immunity	SNX4 HLA-A HLA-B HLA-C TLR4 TAP2	8.76e-05	309	49	6	GO:0002703
GeneOntologyBiologicalProcess	positive regulation of immune effector process	SNX4 HLA-A HLA-B HLA-C TLR4 TAP2	1.01e-04	317	49	6	GO:0002699
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated cytotoxicity	HLA-A HLA-B TAP2	1.17e-04	40	49	3	GO:0045953
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated immunity	HLA-A HLA-B TAP2	1.26e-04	41	49	3	GO:0002716
GeneOntologyBiologicalProcess	regulation of T cell mediated immunity	HLA-A HLA-B HLA-C TAP2	1.40e-04	111	49	4	GO:0002709
GeneOntologyBiologicalProcess	negative regulation of innate immune response	HLA-A HLA-B DCST1 TAP2	1.55e-04	114	49	4	GO:0045824
GeneOntologyBiologicalProcess	detection of biotic stimulus	HLA-A HLA-B TLR4	1.78e-04	46	49	3	GO:0009595
GeneOntologyBiologicalProcess	negative regulation of leukocyte mediated cytotoxicity	HLA-A HLA-B TAP2	1.90e-04	47	49	3	GO:0001911
GeneOntologyBiologicalProcess	mesodermal cell migration	LRP6 LRP5	1.97e-04	9	49	2	GO:0008078
GeneOntologyBiologicalProcess	regulation of leukocyte mediated cytotoxicity	HLA-A HLA-B HLA-C TAP2	2.14e-04	124	49	4	GO:0001910
GeneOntologyBiologicalProcess	negative regulation of cell killing	HLA-A HLA-B TAP2	2.57e-04	52	49	3	GO:0031342
GeneOntologyBiologicalProcess	regulation of secretion by cell	GIPR SNX4 ADRA2B HTR1D TLR4 LRP1 LRP5 SV2C	3.24e-04	740	49	8	GO:1903530
GeneOntologyBiologicalProcess	antigen processing and presentation	HLA-A HLA-B HLA-C TAP2	3.31e-04	139	49	4	GO:0019882
GeneOntologyBiologicalProcess	regulation of cell killing	HLA-A HLA-B HLA-C TAP2	4.09e-04	147	49	4	GO:0031341
GeneOntologyBiologicalProcess	positive regulation of lymphocyte mediated immunity	HLA-A HLA-B HLA-C TAP2	4.41e-04	150	49	4	GO:0002708
GeneOntologyBiologicalProcess	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	HLA-A HLA-B HLA-C TAP2	4.41e-04	150	49	4	GO:0002824
GeneOntologyBiologicalProcess	negative regulation of response to biotic stimulus	HLA-A HLA-B DCST1 TAP2	4.53e-04	151	49	4	GO:0002832
GeneOntologyBiologicalProcess	secretion	GIPR SNX4 CAD ADRA2B HTR1D TLR4 LRP1 LRP5 SV2C CHRM1	5.03e-04	1221	49	10	GO:0046903
GeneOntologyBiologicalProcess	regulation of secretion	GIPR SNX4 ADRA2B HTR1D TLR4 LRP1 LRP5 SV2C	5.49e-04	801	49	8	GO:0051046
GeneOntologyBiologicalProcess	positive regulation of adaptive immune response	HLA-A HLA-B HLA-C TAP2	5.50e-04	159	49	4	GO:0002821
GeneOntologyBiologicalProcess	positive regulation of chemokine (C-X-C motif) ligand 2 production	TLR4 LRP1	5.69e-04	15	49	2	GO:2000343
GeneOntologyBiologicalProcess	regulation of neuron projection development	SNX3 HLA-A HLA-B HLA-C ADGRB3 LRP1 LRP6	5.69e-04	612	49	7	GO:0010975
GeneOntologyBiologicalProcess	T cell mediated immunity	HLA-A HLA-B HLA-C TAP2	6.04e-04	163	49	4	GO:0002456
GeneOntologyBiologicalProcess	negative regulation of neuron projection development	HLA-A HLA-B HLA-C LRP1	6.91e-04	169	49	4	GO:0010977
GeneOntologyBiologicalProcess	neuron projection development	SNX3 HLA-A HLA-B HLA-C ADGRB1 ADGRB3 LRP1 LRP6 DSCAML1 LGI1	7.50e-04	1285	49	10	GO:0031175
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity	HLA-A HLA-B TAP2	7.84e-04	76	49	3	GO:0042269
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated immunity	HLA-A HLA-B HLA-C TAP2	7.88e-04	175	49	4	GO:0002705
GeneOntologyBiologicalProcess	signal release	GIPR SNX4 ADRA2B HTR1D LRP1 LRP5 SV2C	8.35e-04	653	49	7	GO:0023061
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immunity	HLA-A HLA-B TAP2	9.10e-04	80	49	3	GO:0002715
GeneOntologyBiologicalProcess	establishment of blood-brain barrier	LRP6 LRP5	9.21e-04	19	49	2	GO:0060856
GeneOntologyBiologicalProcess	regulation of establishment of protein localization	GIPR SNX3 CSNK2A2 TLR4 LRP1 LRP5 CHRM1	1.00e-03	674	49	7	GO:0070201
GeneOntologyBiologicalProcess	leukocyte mediated cytotoxicity	HLA-A HLA-B HLA-C TAP2	1.01e-03	187	49	4	GO:0001909
GeneOntologyBiologicalProcess	negative regulation of lymphocyte mediated immunity	HLA-A HLA-B TAP2	1.01e-03	83	49	3	GO:0002707
GeneOntologyBiologicalProcess	detection of bacterium	HLA-A HLA-B	1.02e-03	20	49	2	GO:0016045
GeneOntologyBiologicalProcess	cell migration involved in gastrulation	LRP6 LRP5	1.02e-03	20	49	2	GO:0042074
GeneOntologyBiologicalProcess	positive regulation of autophagosome assembly	SNX30 SNX4	1.02e-03	20	49	2	GO:2000786
GeneOntologyBiologicalProcess	adenylate cyclase-activating G protein-coupled receptor signaling pathway	GIPR ADRA2B ADGRB1 ADGRB3	1.09e-03	191	49	4	GO:0007189
GeneOntologyBiologicalProcess	regulation of immune effector process	SNX4 HLA-A HLA-B HLA-C TLR4 TAP2	1.10e-03	497	49	6	GO:0002697
GeneOntologyBiologicalProcess	G protein-coupled serotonin receptor signaling pathway	HTR1D CHRM1	1.35e-03	23	49	2	GO:0098664
GeneOntologyBiologicalProcess	export from cell	GIPR SNX4 ADRA2B HTR1D KCNT2 TLR4 LRP1 LRP5 SV2C	1.40e-03	1153	49	9	GO:0140352
GeneOntologyBiologicalProcess	chemokine (C-X-C motif) ligand 2 production	TLR4 LRP1	1.48e-03	24	49	2	GO:0072567
GeneOntologyBiologicalProcess	regulation of chemokine (C-X-C motif) ligand 2 production	TLR4 LRP1	1.48e-03	24	49	2	GO:2000341
GeneOntologyBiologicalProcess	endocytic recycling	SNX30 SNX4 SNX3	1.50e-03	95	49	3	GO:0032456
GeneOntologyBiologicalProcess	negative regulation of leukocyte mediated immunity	HLA-A HLA-B TAP2	1.54e-03	96	49	3	GO:0002704
GeneOntologyBiologicalProcess	positive regulation of vacuole organization	SNX30 SNX4	1.60e-03	25	49	2	GO:0044090
GeneOntologyBiologicalProcess	positive regulation of reactive oxygen species biosynthetic process	TLR4 ADGRB1	1.73e-03	26	49	2	GO:1903428
GeneOntologyCellularComponent	MHC class I peptide loading complex	HLA-A HLA-B HLA-C TAP2	2.41e-08	14	48	4	GO:0042824
GeneOntologyCellularComponent	early endosome membrane	WDR91 SNX30 SNX4 SNX3 HLA-A HLA-B HLA-C LRP6	2.61e-08	212	48	8	GO:0031901
GeneOntologyCellularComponent	early endosome	WDR91 SNX30 SNX4 SNX3 HLA-A HLA-B HLA-C TLR4 LRP1 LRP6	1.13e-07	481	48	10	GO:0005769
GeneOntologyCellularComponent	MHC class Ib protein complex	HLA-A HLA-B HLA-C	3.95e-07	7	48	3	GO:0032398
GeneOntologyCellularComponent	MHC class I protein complex	HLA-A HLA-B HLA-C	1.35e-06	10	48	3	GO:0042612
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	WDR91 SNX30 SNX4 SNX3 HLA-A HLA-B HLA-C TLR4 LRP1 LRP6 SV2C DCST1 TAP2	5.17e-06	1307	48	13	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	WDR91 SNX30 SNX4 SNX3 HLA-A HLA-B HLA-C TLR4 LRP1 LRP6 SV2C DCST1 TAP2	6.01e-06	1325	48	13	GO:0012506
GeneOntologyCellularComponent	cis-Golgi network membrane	HLA-A HLA-B HLA-C	7.55e-06	17	48	3	GO:0033106
GeneOntologyCellularComponent	endosome membrane	WDR91 SNX30 SNX4 SNX3 HLA-A HLA-B HLA-C TLR4 LRP6	7.89e-06	602	48	9	GO:0010008
GeneOntologyCellularComponent	Golgi medial cisterna	HLA-A HLA-B HLA-C	1.95e-05	23	48	3	GO:0005797
GeneOntologyCellularComponent	MHC protein complex	HLA-A HLA-B HLA-C	2.85e-05	26	48	3	GO:0042611
GeneOntologyCellularComponent	phagocytic vesicle	SNX3 HLA-A HLA-B HLA-C TAP2	2.96e-05	157	48	5	GO:0045335
GeneOntologyCellularComponent	phagocytic vesicle membrane	HLA-A HLA-B HLA-C TAP2	3.94e-05	83	48	4	GO:0030670
GeneOntologyCellularComponent	Wnt-Frizzled-LRP5/6 complex	LRP6 LRP5	5.14e-05	5	48	2	GO:1990851
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-A HLA-B HLA-C	7.06e-05	35	48	3	GO:0098553
GeneOntologyCellularComponent	endoplasmic reticulum exit site	HLA-A HLA-B HLA-C	1.22e-04	42	48	3	GO:0070971
GeneOntologyCellularComponent	endocytic vesicle membrane	HLA-A HLA-B HLA-C LRP1 TAP2	1.23e-04	212	48	5	GO:0030666
GeneOntologyCellularComponent	lumenal side of membrane	HLA-A HLA-B HLA-C	1.83e-04	48	48	3	GO:0098576
GeneOntologyCellularComponent	endoplasmic reticulum protein-containing complex	HLA-A HLA-B HLA-C TAP2	1.93e-04	125	48	4	GO:0140534
GeneOntologyCellularComponent	endocytic vesicle	SNX3 HLA-A HLA-B HLA-C LRP1 TAP2	2.36e-04	384	48	6	GO:0030139
GeneOntologyCellularComponent	dynein complex	SNX4 DNAH17 DNAH7	2.60e-04	54	48	3	GO:0030286
GeneOntologyCellularComponent	Golgi cisterna	HLA-A HLA-B HLA-C ST3GAL4	2.60e-04	135	48	4	GO:0031985
GeneOntologyCellularComponent	endosome	WDR91 SNX30 SNX4 SNX3 HLA-A HLA-B HLA-C TLR4 LRP1 LRP6	2.65e-04	1167	48	10	GO:0005768
GeneOntologyCellularComponent	ER to Golgi transport vesicle membrane	HLA-A HLA-B HLA-C	4.29e-04	64	48	3	GO:0012507
GeneOntologyCellularComponent	Wnt signalosome	LRP6 LRP5	6.07e-04	16	48	2	GO:1990909
GeneOntologyCellularComponent	Golgi stack	HLA-A HLA-B HLA-C ST3GAL4	6.35e-04	171	48	4	GO:0005795
GeneOntologyCellularComponent	cis-Golgi network	HLA-A HLA-B HLA-C	9.83e-04	85	48	3	GO:0005801
GeneOntologyCellularComponent	coated vesicle	SNX3 HLA-A HLA-B HLA-C LRP1	1.37e-03	360	48	5	GO:0030135
GeneOntologyCellularComponent	axonemal dynein complex	DNAH17 DNAH7	1.50e-03	25	48	2	GO:0005858
GeneOntologyCellularComponent	membrane protein complex	SNX4 SNX3 HLA-A HLA-B HLA-C TLR4 LRP1 LRP6 LRP5 TAP2	1.84e-03	1498	48	10	GO:0098796
GeneOntologyCellularComponent	COPII-coated ER to Golgi transport vesicle	HLA-A HLA-B HLA-C	2.06e-03	110	48	3	GO:0030134
GeneOntologyCellularComponent	recycling endosome membrane	HLA-A HLA-B HLA-C	2.17e-03	112	48	3	GO:0055038
GeneOntologyCellularComponent	phagocytic cup	TLR4 ADGRB1	2.30e-03	31	48	2	GO:0001891
GeneOntologyCellularComponent	synaptic cleft	ADGRB3 LGI1	2.61e-03	33	48	2	GO:0043083
GeneOntologyCellularComponent	cell surface	ADRA2B HLA-A HLA-B HLA-C TLR4 LRP1 LRP6 DSCAML1	3.52e-03	1111	48	8	GO:0009986
GeneOntologyCellularComponent	transport vesicle membrane	HLA-A HLA-B HLA-C SV2C	4.53e-03	293	48	4	GO:0030658
GeneOntologyCellularComponent	postsynaptic density membrane	ADGRB3 LRP1 CHRM1	5.61e-03	157	48	3	GO:0098839
GeneOntologyCellularComponent	microtubule associated complex	SNX4 DNAH17 DNAH7	6.02e-03	161	48	3	GO:0005875
GeneOntologyCellularComponent	external side of plasma membrane	HLA-A HLA-B HLA-C TLR4 LRP1	6.58e-03	519	48	5	GO:0009897
GeneOntologyCellularComponent	secretory vesicle	HTR1D HLA-B HLA-C GUSB CSNK2A2 LRP1 SV2C DCST1	6.98e-03	1246	48	8	GO:0099503
GeneOntologyCellularComponent	secretory granule	HTR1D HLA-B HLA-C GUSB CSNK2A2 LRP1 DCST1	8.01e-03	1014	48	7	GO:0030141
GeneOntologyCellularComponent	plasma membrane protein complex	HLA-A HLA-B HLA-C LRP1 LRP6 LRP5	8.81e-03	785	48	6	GO:0098797
GeneOntologyCellularComponent	membrane raft	HLA-A HLA-B HLA-C LRP6	9.45e-03	362	48	4	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	HLA-A HLA-B HLA-C LRP6	9.63e-03	364	48	4	GO:0098857
GeneOntologyCellularComponent	glutamatergic synapse	HTR1D ADGRB1 ADGRB3 LRP1 CHRM1 LGI1	1.06e-02	817	48	6	GO:0098978
GeneOntologyCellularComponent	postsynaptic specialization membrane	ADGRB3 LRP1 CHRM1	1.10e-02	201	48	3	GO:0099634
MousePheno	spinal cord inflammation	HLA-A HLA-B HLA-C	1.40e-06	8	42	3	MP:0030987
MousePheno	abnormal adiponectin level	ALKBH7 TLR4 LRP6 KBTBD2	4.17e-05	65	42	4	MP:0004891
Domain	MHC_I_a_C	HLA-A HLA-B HLA-C	2.97e-07	6	47	3	IPR010579
Domain	MHC_I_C	HLA-A HLA-B HLA-C	2.97e-07	6	47	3	PF06623
Domain	PX	SNX30 SNX4 SNX3 SNX29	4.44e-06	44	47	4	SM00312
Domain	Ldl_recept_b	LRP1 LRP6 LRP5	5.33e-06	14	47	3	PF00058
Domain	LDLRB	LRP1 LRP6 LRP5	5.33e-06	14	47	3	PS51120
Domain	LRP5/6	LRP6 LRP5	6.20e-06	2	47	2	IPR017049
Domain	LY	LRP1 LRP6 LRP5	6.65e-06	15	47	3	SM00135
Domain	LDLR_classB_rpt	LRP1 LRP6 LRP5	6.65e-06	15	47	3	IPR000033
Domain	PX	SNX30 SNX4 SNX3 SNX29	6.86e-06	49	47	4	PF00787
Domain	PX	SNX30 SNX4 SNX3 SNX29	7.45e-06	50	47	4	PS50195
Domain	-	SNX30 SNX4 SNX3 SNX29	8.06e-06	51	47	4	3.30.1520.10
Domain	Phox	SNX30 SNX4 SNX3 SNX29	8.72e-06	52	47	4	IPR001683
Domain	GPCR_2_brain_angio_inhib	ADGRB1 ADGRB3	1.86e-05	3	47	2	IPR008077
Domain	MHC_I	HLA-A HLA-B HLA-C	1.92e-05	21	47	3	PF00129
Domain	MHC_I_a_a1/a2	HLA-A HLA-B HLA-C	1.92e-05	21	47	3	IPR001039
Domain	-	HLA-A HLA-B HLA-C	2.91e-05	24	47	3	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-A HLA-B HLA-C	2.91e-05	24	47	3	IPR011161
Domain	HormR	GIPR ADGRB1 ADGRB3	3.30e-05	25	47	3	SM00008
Domain	HRM	GIPR ADGRB1 ADGRB3	4.68e-05	28	47	3	PF02793
Domain	MHC_I/II-like_Ag-recog	HLA-A HLA-B HLA-C	1.18e-04	38	47	3	IPR011162
Domain	-	LRP1 LRP6 LRP5	1.28e-04	39	47	3	2.120.10.30
Domain	G_PROTEIN_RECEP_F2_1	GIPR ADGRB1 ADGRB3	1.38e-04	40	47	3	PS00649
Domain	GPCR_2_extracellular_dom	GIPR ADGRB1 ADGRB3	1.38e-04	40	47	3	IPR001879
Domain	LDLR_class-A_CS	LRP1 LRP6 LRP5	1.38e-04	40	47	3	IPR023415
Domain	G_PROTEIN_RECEP_F2_3	GIPR ADGRB1 ADGRB3	1.38e-04	40	47	3	PS50227
Domain	Ldl_recept_a	LRP1 LRP6 LRP5	1.97e-04	45	47	3	PF00057
Domain	-	LRP1 LRP6 LRP5	2.10e-04	46	47	3	4.10.400.10
Domain	6-blade_b-propeller_TolB-like	LRP1 LRP6 LRP5	2.10e-04	46	47	3	IPR011042
Domain	LDLRA_1	LRP1 LRP6 LRP5	2.39e-04	48	47	3	PS01209
Domain	LDLRA_2	LRP1 LRP6 LRP5	2.54e-04	49	47	3	PS50068
Domain	LDrepeatLR_classA_rpt	LRP1 LRP6 LRP5	2.54e-04	49	47	3	IPR002172
Domain	LDLa	LRP1 LRP6 LRP5	2.54e-04	49	47	3	SM00192
Domain	G_PROTEIN_RECEP_F2_2	GIPR ADGRB1 ADGRB3	2.69e-04	50	47	3	PS00650
Domain	7tm_2	GIPR ADGRB1 ADGRB3	2.69e-04	50	47	3	PF00002
Domain	GAIN_dom_N	ADGRB1 ADGRB3	3.36e-04	11	47	2	IPR032471
Domain	GAIN	ADGRB1 ADGRB3	3.36e-04	11	47	2	PF16489
Domain	C1-set	HLA-A HLA-B HLA-C	3.39e-04	54	47	3	PF07654
Domain	IGc1	HLA-A HLA-B HLA-C	3.77e-04	56	47	3	SM00407
Domain	Ig_C1-set	HLA-A HLA-B HLA-C	4.18e-04	58	47	3	IPR003597
Domain	Ig/MHC_CS	HLA-A HLA-B HLA-C	4.18e-04	58	47	3	IPR003006
Domain	GPCR_2_secretin-like	GIPR ADGRB1 ADGRB3	4.62e-04	60	47	3	IPR000832
Domain	GPCR_2-like	GIPR ADGRB1 ADGRB3	4.62e-04	60	47	3	IPR017981
Domain	IG_MHC	HLA-A HLA-B HLA-C	4.62e-04	60	47	3	PS00290
Domain	G_PROTEIN_RECEP_F2_4	GIPR ADGRB1 ADGRB3	4.85e-04	61	47	3	PS50261
Domain	LRRCT	TLR4 LGI1	2.93e-03	32	47	2	PF01463
Domain	GPS	ADGRB1 ADGRB3	3.30e-03	34	47	2	SM00303
Domain	GPCR_2_secretin-like_CS	GIPR ADGRB3	3.30e-03	34	47	2	IPR017983
Domain	GPS	ADGRB1 ADGRB3	3.50e-03	35	47	2	PF01825
Domain	GPS	ADGRB1 ADGRB3	3.70e-03	36	47	2	PS50221
Domain	GPS	ADGRB1 ADGRB3	3.90e-03	37	47	2	IPR000203
Domain	EGF	LRP1 LRP6 LRP5	3.92e-03	126	47	3	PF00008
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C TAP2	2.71e-08	12	40	4	M47529
Pathway	REACTOME_ER_PHAGOSOME_PATHWAY	HLA-A HLA-B HLA-C TAP2	1.65e-07	18	40	4	MM14525
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	4.21e-07	6	40	3	M47468
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-C TAP2	6.73e-07	25	40	4	MM15713
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	7.35e-07	7	40	3	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	7.35e-07	7	40	3	M47530
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-C TAP2	1.25e-06	29	40	4	M1062
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-C	1.76e-06	9	40	3	MM14527
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-C	3.44e-06	11	40	3	M525
Pathway	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	HLA-A HLA-B HLA-C TLR4 TAP2	1.17e-05	106	40	5	M518
Pathway	BIOCARTA_CTL_PATHWAY	HLA-A HLA-B HLA-C	2.33e-05	20	40	3	MM1374
Pathway	BIOCARTA_NKCELLS_PATHWAY	HLA-A HLA-B HLA-C	4.66e-05	25	40	3	MM1465
Pathway	WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA	LRP6 LRP5 RUNX1T1	5.26e-05	26	40	3	M39407
Pathway	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	HLA-A HLA-B HLA-C TAP2	6.15e-05	76	40	4	MM14526
Pathway	WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS	LRP6 LRP5	7.81e-05	5	40	2	M48304
Pathway	WP_MONOAMINE_GPCRS	ADRA2B HTR1D CHRM1	9.00e-05	31	40	3	MM15871
Pathway	WP_GPCRS_NONODORANT	GIPR ADRA2B HTR1D ADGRB1 ADGRB3 CHRM1	9.55e-05	266	40	6	MM15843
Pathway	WP_MONOAMINE_GPCRS	ADRA2B HTR1D CHRM1	1.09e-04	33	40	3	M39585
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	HLA-A HLA-B HLA-C TAP2	1.09e-04	88	40	4	M16004
Pathway	WP_ALLOGRAFT_REJECTION	HLA-A HLA-B HLA-C CSNK2A2	1.14e-04	89	40	4	M39398
Pathway	KEGG_ALLOGRAFT_REJECTION	HLA-A HLA-B HLA-C	1.54e-04	37	40	3	M18615
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	HLA-A HLA-B HLA-C	2.09e-04	41	40	3	M13519
Pathway	REACTOME_SIGNALING_BY_RNF43_MUTANTS	LRP6 LRP5	2.17e-04	8	40	2	M27433
Pathway	REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS	LRP6 LRP5	2.17e-04	8	40	2	MM14976
Pathway	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	ADRA2B HTR1D CHRM1	2.25e-04	42	40	3	M5868
Pathway	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	ADRA2B HTR1D CHRM1	2.25e-04	42	40	3	MM14971
Pathway	KEGG_TYPE_I_DIABETES_MELLITUS	HLA-A HLA-B HLA-C	2.41e-04	43	40	3	M12617
Pathway	WP_WNT_SIGNALING_PATHWAY	CSNK2A2 LRP1 LRP6 LRP5	2.58e-04	110	40	4	MM15977
Pathway	KEGG_AUTOIMMUNE_THYROID_DISEASE	HLA-A HLA-B HLA-C	4.25e-04	52	40	3	M13103
Pathway	REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES	HLA-A HLA-B HLA-C NUP160	4.33e-04	126	40	4	M45009
Pathway	WP_EBOLA_VIRUS_INFECTION_IN_HOST	HLA-A HLA-B HLA-C TLR4	4.74e-04	129	40	4	M39693
Pathway	REACTOME_DAP12_INTERACTIONS	HLA-A HLA-B HLA-C	4.75e-04	54	40	3	MM14871
Pathway	BIOCARTA_MHC_PATHWAY	HLA-A TAP2	6.99e-04	14	40	2	M22023
Pathway	KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4	LRP6 LRP5	6.99e-04	14	40	2	M47834
Pathway	WP_PROTEASOME_DEGRADATION	HLA-A HLA-B HLA-C	7.13e-04	62	40	3	M39639
Pathway	WP_TAR_SYNDROME	HLA-A HLA-B HLA-C	7.47e-04	63	40	3	M48082
Pathway	REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS	LRP6 LRP5	8.05e-04	15	40	2	M27273
Pathway	KEGG_VIRAL_MYOCARDITIS	HLA-A HLA-B HLA-C	1.02e-03	70	40	3	M12294
Pathway	WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS	TLR4 LRP6 LRP5	1.10e-03	72	40	3	M39403
Pathway	WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS	TLR4 LRP6 LRP5	1.15e-03	73	40	3	MM15906
Pathway	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	HLA-A HLA-B HLA-C	1.39e-03	78	40	3	M973
Pathway	REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION	LRP6 LRP5	1.44e-03	20	40	2	MM15155
Pathway	REACTOME_SARS_COV_2_INFECTION	HLA-A HLA-B HLA-C ST3GAL4 NUP160	1.49e-03	299	40	5	M41727
Pathway	REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION	LRP6 LRP5	1.59e-03	21	40	2	M27401
Pathway	WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA	CSNK2A2 LRP6 LRP5	2.03e-03	89	40	3	M39563
Pathway	REACTOME_SARS_COV_2_HOST_INTERACTIONS	HLA-A HLA-B HLA-C NUP160	2.59e-03	204	40	4	M45011
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH17 DNAH7	2.63e-03	27	40	2	M47755
Pathway	WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER	CSNK2A2 LRP6 LRP5	2.67e-03	98	40	3	M39731
Pathway	REACTOME_INTERFERON_GAMMA_SIGNALING	HLA-A HLA-B HLA-C	2.67e-03	98	40	3	M965
Pathway	PID_WNT_SIGNALING_PATHWAY	LRP6 LRP5	2.83e-03	28	40	2	M77
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA	GLE1 NUP160	3.25e-03	30	40	2	M47752
Pathway	REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE	LRP6 LRP5	3.47e-03	31	40	2	M27400
Pathway	REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE	LRP6 LRP5	3.47e-03	31	40	2	MM15154
Pathway	WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA	LRP6 LRP5	3.92e-03	33	40	2	M39870
Pathway	WP_WNT_SIGNALING_WP428	CSNK2A2 LRP6 LRP5	3.99e-03	113	40	3	M39669
Pathway	REACTOME_SIGNALING_BY_WNT_IN_CANCER	LRP6 LRP5	4.16e-03	34	40	2	M27405
Pathway	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	HLA-A HLA-B HLA-C TLR4 TAP2	4.25e-03	381	40	5	M1066
Pathway	REACTOME_SIGNALING_BY_WNT	SNX3 CSNK2A2 LRP6 LRP5	4.56e-03	239	40	4	MM14756
Pathway	WP_WNT_SIGNALING_IN_KIDNEY_DISEASE	LRP6 LRP5	4.65e-03	36	40	2	M39699
Pubmed	Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.	HLA-A HLA-B HLA-C TAP2	4.74e-10	9	50	4	8805302
Pubmed	Association of beta2-microglobulin with the alpha3 domain of H-2Db heavy chain.	HLA-A HLA-B HLA-C TAP2	7.88e-10	10	50	4	14735325
Pubmed	Regulation of major histocompatibility complex and TAP gene products in preimplantation mouse stage embryos.	HLA-A HLA-B HLA-C TAP2	7.88e-10	10	50	4	9764360
Pubmed	Ham-2 corrects the class I antigen-processing defect in RMA-S cells.	HLA-A HLA-B HLA-C TAP2	1.85e-09	12	50	4	1538753
Pubmed	Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain.	HLA-A HLA-B HLA-C TAP2	2.68e-09	13	50	4	9973410
Pubmed	Filling the gaps - the generation of full genomic sequences for 15 common and well-documented HLA class I alleles using next-generation sequencing technology.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	23246585
Pubmed	The detailed distribution of HLA-A, B, C antigens in normal human organs.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	6591601
Pubmed	Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	11390610
Pubmed	HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	19694795
Pubmed	[Association of gene HLA-class I with leukemia].	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	16129034
Pubmed	Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15301865
Pubmed	[Studies of the relationship of HLA polymorphisms and the infection of H. pylori in the population of Linqu in Shandong Province].	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15662734
Pubmed	Impact of HLA-A,B,C allele mismatches on outcome after unrelated blood stem cell transplantation in whites.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15480178
Pubmed	HLA-C(*)03 is a risk factor for cardiomyopathy in Chagas disease.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	11053636
Pubmed	HLA-A11:01:01:01, HLA-C12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	33968060
Pubmed	The role of HLA class I gene variation in autoimmune diabetes.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17491685
Pubmed	Association of human leukocyte antigen class I antigens in Iranian patients with pemphigus vulgaris.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	23330836
Pubmed	HLA-A02:01:01/-B35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	25495410
Pubmed	Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	21209113
Pubmed	Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	19774073
Pubmed	Serological HLA class I alleles in Senegalese blood donors detected HBs Ag positive.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	11064107
Pubmed	HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17878955
Pubmed	HIV-1 accessory proteins: Nef.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	24158818
Pubmed	Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	18684953
Pubmed	Allelic distribution of HLA class I genes in the Tibetan ethnic population of China.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17117954
Pubmed	HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17909631
Pubmed	Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	10715516
Pubmed	Four new HLA class I alleles in Cauacasoids.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15982258
Pubmed	The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	21482733
Pubmed	Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15009803
Pubmed	Polymorphism of HLA class I genes in Meizhou Han population of Guangdong, China.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17373939
Pubmed	HLA-A*24020102L in the UK blood donor population.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15140038
Pubmed	[Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela].	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	14727382
Pubmed	HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal Study.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	33863792
Pubmed	Host genetics and HIV-1 viral load set-point in African-Americans.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	19276793
Pubmed	Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	14501786
Pubmed	Human leukocyte antigens as genetic markers in Greek patients with sporadic pancreatic cancer.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15211110
Pubmed	Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	20660184
Pubmed	HLA class I polymorphism in the Cuban population.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	18082573
Pubmed	HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A2612-B4407 haplotype.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	16451198
Pubmed	Molecular diversity of HLA-A, -B and -C alleles in a North Indian population as determined by PCR-SSOP.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17504510
Pubmed	HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	22826228
Pubmed	HLA-A, HLA-B and HLA-C polymorphism in the Slovak population.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	10954160
Pubmed	Association between HLA inheritance and asthma medication use in HIV positive children.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	20613458
Pubmed	NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	24554773
Pubmed	Association of HLA class I alleles with psoriasis vulgaris in southeastern Chinese Hans.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	14527733
Pubmed	Association of human leukocyte antigen and esophageal cancer in North of Iran.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	20334121
Pubmed	The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	9104816
Pubmed	HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	20504258
Pubmed	Distributions of HLA class I alleles and haplotypes in Northern Han Chinese.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	16185325
Pubmed	Locus-specific constitutive and cytokine-induced HLA class I gene expression.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	12574356
Pubmed	Hla-Cw7 allele as predictor of favorable therapeutic response to interferon-alpha in patients with chronic hepatitis C.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	18074415
Pubmed	[Haplotype and linkage analysis of HLA-I classical genes in Chinese Han population].	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17956696
Pubmed	Orientation of loci within the human major histocompatibility complex by chromosomal in situ hybridization.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	6585830
Pubmed	Targeting HIV-1 Gag into the defective ribosomal product pathway enhances MHC class I antigen presentation and CD8+ T cell activation.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	18097038
Pubmed	Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	11927505
Pubmed	Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	19663693
Pubmed	Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	28278336
Pubmed	Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	16331510
Pubmed	Allelic diversity and haplotype structure of HLA loci in the Chinese Han population living in the Guanzhong region of the Shaanxi province.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	20219611
Pubmed	HIV and human leukocyte antigen association--the Indian scenario.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15534563
Pubmed	HLA B*44: protective effects in MS susceptibility and MRI outcome measures.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	20713950
Pubmed	Polymorphism of HLA class I genes in the Brazilian population from the Northeastern State of Pernambuco corroborates anthropological evidence of its origin.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15245377
Pubmed	Human leukocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: relationship to other populations.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15245373
Pubmed	Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15220037
Pubmed	Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	18580606
Pubmed	The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	11120862
Pubmed	Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	22553319
Pubmed	HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	18434400
Pubmed	Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17471440
Pubmed	Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	8617941
Pubmed	HLA diversity among Nadars, a primitive Dravidian caste of South India.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	14617038
Pubmed	Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	24717292
Pubmed	CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	20065064
Pubmed	Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	28650991
Pubmed	Novel HLA Class I Alleles Associated with Indian Leprosy Patients.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	12975536
Pubmed	Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17207712
Pubmed	Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	19232441
Pubmed	Association of HLA class I alleles with keloids in Chinese Han individuals.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	19932885
Pubmed	HLA class I polymorphism, as characterised by PCR-SSOP, in a Brazilian exogamic population.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	11144289
Pubmed	[Immunogenetic HLA markers of chronic viral hepatitis].	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15807454
Pubmed	Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	11543903
Pubmed	High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	25781986
Pubmed	HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	18521626
Pubmed	Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	12372094
Pubmed	Evolutionary relationship between immunoglobulins and transplantation antigens.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	1055432
Pubmed	Unusual HLA-B alleles in two tribes of Brazilian Indians.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	1317015
Pubmed	Association of HLA class I alleles with aloplecia areata in Chinese Hans.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	16185849
Pubmed	Behçet disease, new insights in disease associations and manifestations: a next-generation sequencing study.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	33421092
Pubmed	Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	21352198
Pubmed	HLA class I diversity in Kolla Amerindians.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	11182228
Pubmed	HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	36605212
Pubmed	Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17258541
Pubmed	HLA associations in leprosy patients from Mumbai, India.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	15072129
Pubmed	HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	19019964
Pubmed	HLA class I polymorphism in Mongolian and Hui ethnic groups from Northern China.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	17462512
Pubmed	Polymorphic insertions in 5 Alu loci within the major histocompatibility complex class I region and their linkage disequilibria with HLA alleles in four distinct populations in mainland China.	HLA-A HLA-B HLA-C	2.80e-09	3	50	3	19054371
Pubmed	Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.	HLA-A HLA-B HLA-C	1.12e-08	4	50	3	12594841
Pubmed	Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure.	HLA-A HLA-B HLA-C	1.12e-08	4	50	3	25193656
Pubmed	Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India.	HLA-A HLA-B HLA-C	1.12e-08	4	50	3	12651075
Interaction	HLA-G interactions	HLA-A HLA-B HLA-C LRP6 LRP5 TAP2	4.04e-07	118	49	6	int:HLA-G
Interaction	TAPBP interactions	HLA-A HLA-B HLA-C ASIC4 TAP2	5.94e-07	67	49	5	int:TAPBP
Interaction	ADAM33 interactions	HLA-A HLA-B HLA-C LRP6 LRP5	1.36e-06	79	49	5	int:ADAM33
Interaction	LILRB1 interactions	HLA-A HLA-B HLA-C	1.60e-06	10	49	3	int:LILRB1
Interaction	LILRB2 interactions	HLA-A HLA-B HLA-C	1.60e-06	10	49	3	int:LILRB2
Interaction	ADAM30 interactions	HLA-A HLA-C LRP6 LRP5	1.03e-05	56	49	4	int:ADAM30
Interaction	IL5RA interactions	HLA-C GUSB LRP6 LRP5 ST3GAL4	1.25e-05	124	49	5	int:IL5RA
Interaction	CD8A interactions	HLA-A HLA-B HLA-C	3.38e-05	26	49	3	int:CD8A
Interaction	HLA-E interactions	HLA-A HLA-B HLA-C TAP2	4.05e-05	79	49	4	int:HLA-E
Interaction	HLA-DQB1 interactions	HLA-A HLA-B HLA-C ASIC4	4.69e-05	82	49	4	int:HLA-DQB1
Interaction	KIR3DL3 interactions	HLA-A HLA-B HLA-C	5.24e-05	30	49	3	int:KIR3DL3
Interaction	TNFSF9 interactions	HLA-B HLA-C TLR4 ASIC4	5.92e-05	87	49	4	int:TNFSF9
Interaction	B2M interactions	HLA-A HLA-B HLA-C TAP2	7.36e-05	92	49	4	int:B2M
Interaction	GRIN2A interactions	CSNK2A2 LRP1 LRP6 TAP2	7.68e-05	93	49	4	int:GRIN2A
Interaction	TAP2 interactions	HLA-A HLA-B HLA-C TAP2	8.01e-05	94	49	4	int:TAP2
Interaction	RAB9A interactions	WDR91 SNX30 SNX3 HLA-A HACD3 ADGRB1 ECH1 SNX29	8.54e-05	595	49	8	int:RAB9A
Interaction	TCTN2 interactions	HLA-A HLA-B HLA-C HACD3 ASIC4 TAP2	9.09e-05	304	49	6	int:TCTN2
Interaction	GPATCH2 interactions	CSNK2A2 LRP6 LRP5	9.11e-05	36	49	3	int:GPATCH2
Interaction	KLRD1 interactions	HLA-B HLA-C ST3GAL4 TAP2	1.19e-04	104	49	4	int:KLRD1
Interaction	LRP5 interactions	LRP6 LRP5 ST3GAL4 LGI1	1.42e-04	109	49	4	int:LRP5
Interaction	FCGRT interactions	SNX3 HLA-B LRP6 LRP5	1.81e-04	116	49	4	int:FCGRT
Interaction	NCR3 interactions	HLA-C GUSB LRP6 LRP5	2.06e-04	120	49	4	int:NCR3
Interaction	PAK1 interactions	CAD HLA-A HLA-B HLA-C CSNK2A2	2.30e-04	229	49	5	int:PAK1
Interaction	ELOVL5 interactions	HLA-A HLA-C HACD3 LRP6 LRP5 NUP160	2.42e-04	364	49	6	int:ELOVL5
Interaction	PARP16 interactions	HACD3 LRP6 LRP5	2.44e-04	50	49	3	int:PARP16
Interaction	HLA-B interactions	HLA-A HLA-B HLA-C ASIC4 TAP2	2.80e-04	239	49	5	int:HLA-B
Interaction	IFI16 interactions	HLA-A HLA-C HACD3 NOC2L GLE1 CSNK2A2 BAZ1B NUP160	2.97e-04	714	49	8	int:IFI16
Interaction	ASIC4 interactions	HLA-A HLA-B HLA-C ASIC4	3.14e-04	134	49	4	int:ASIC4
Interaction	CAV1 interactions	SNX3 HLA-A HLA-C CSNK2A2 TLR4 LRP1 LRP6 SNX29	3.27e-04	724	49	8	int:CAV1
Interaction	LRFN3 interactions	HLA-C ST3GAL4 LGI1	3.60e-04	57	49	3	int:LRFN3
Interaction	CHST9 interactions	LRP6 LRP5	3.76e-04	12	49	2	int:CHST9
Interaction	LYPD1 interactions	HLA-C LRP6 LRP5	3.79e-04	58	49	3	int:LYPD1
Interaction	ST3GAL4 interactions	LRP6 LRP5 ST3GAL4	3.99e-04	59	49	3	int:ST3GAL4
Interaction	MR1 interactions	HLA-B HLA-C ASIC4	4.19e-04	60	49	3	int:MR1
Interaction	CLEC2B interactions	HLA-A HLA-C LRP6 LRP5	4.46e-04	147	49	4	int:CLEC2B
Interaction	RNF4 interactions	HLA-A HLA-B HLA-C HACD3 NOC2L GLE1 LRP1 BAZ1B RUNX1T1 TAP2 NUP160	4.70e-04	1412	49	11	int:RNF4
Interaction	KLK15 interactions	SNX3 GUSB LRP6 LRP5	4.94e-04	151	49	4	int:KLK15
Interaction	PTCH1 interactions	HLA-A HLA-B HLA-C CSNK2A2 ST3GAL4	5.15e-04	273	49	5	int:PTCH1
Interaction	BTNL2 interactions	HLA-A HLA-C GUSB LRP6	5.45e-04	155	49	4	int:BTNL2
Interaction	HLA-DRB3 interactions	HLA-A HLA-C ASIC4	5.80e-04	67	49	3	int:HLA-DRB3
Interaction	IL27RA interactions	HLA-B HLA-C ST3GAL4	5.80e-04	67	49	3	int:IL27RA
Interaction	PRSS37 interactions	LRP6 LRP5	5.96e-04	15	49	2	int:PRSS37
Interaction	CLSTN3 interactions	HLA-C ST3GAL4 ASIC4	6.06e-04	68	49	3	int:CLSTN3
Interaction	HLA-A interactions	HLA-A HLA-B HLA-C ASIC4 TAP2	6.67e-04	289	49	5	int:HLA-A
Interaction	WNT1 interactions	LRP6 LRP5	6.80e-04	16	49	2	int:WNT1
Interaction	CAPRIN2 interactions	LRP6 LRP5	6.80e-04	16	49	2	int:CAPRIN2
Cytoband	6p21.3	HLA-A HLA-B HLA-C TAP2	1.62e-04	250	50	4	6p21.3
Cytoband	9q34.11	GLE1 COQ4	1.55e-03	53	50	2	9q34.11
GeneFamily	Sorting nexins\|PX-BAR domain containing	SNX30 SNX4 SNX3 SNX29	3.79e-07	29	38	4	754
GeneFamily	Low density lipoprotein receptors	LRP1 LRP6 LRP5	2.41e-06	13	38	3	634
GeneFamily	Adhesion G protein-coupled receptors, subfamily B	ADGRB1 ADGRB3	1.29e-05	3	38	2	912
GeneFamily	C1-set domain containing	HLA-A HLA-B HLA-C	9.29e-05	42	38	3	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-A HLA-B HLA-C	1.07e-04	44	38	3	588
GeneFamily	Sorting nexins\|PX-BAR domain containing	SNX30 SNX4	2.80e-04	12	38	2	1290
GeneFamily	Dyneins, axonemal	DNAH17 DNAH7	5.73e-04	17	38	2	536
GeneFamily	Nucleoporins	GLE1 NUP160	2.05e-03	32	38	2	1051
GeneFamily	Autophagy related	SNX30 SNX4	2.18e-03	33	38	2	1022
Coexpression	RUAN_RESPONSE_TO_TNF_UP	HLA-A HLA-B HLA-C TAP2	6.84e-08	21	50	4	MM651
Coexpression	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	HLA-A HLA-B HLA-C TAP2	1.44e-07	25	50	4	MM672
Coexpression	GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN	WDR91 HLA-A HLA-B HLA-C ST3GAL4 TAP2	2.20e-06	200	50	6	M9570
Coexpression	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	HLA-A HLA-B HLA-C TAP2	2.33e-06	49	50	4	M8341
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	HLA-A HLA-B HLA-C HACD3 NOC2L LRP1 TAP2 SNX29	2.79e-06	470	50	8	MM1053
Coexpression	TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING	HLA-A HLA-B HLA-C	3.59e-06	16	50	3	MM3766
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	HLA-A HLA-B HLA-C	6.19e-06	19	50	3	MM797
Coexpression	MIKKELSEN_NPC_ICP_WITH_H3K27ME3	HLA-A HLA-B HLA-C	6.19e-06	19	50	3	MM862
Coexpression	TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING	HLA-A HLA-B HLA-C	7.28e-06	20	50	3	MM3682
Coexpression	TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING	HLA-A HLA-B HLA-C	1.29e-05	24	50	3	MM3773
Coexpression	DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS	SNX30 HLA-A HLA-B HLA-C GUSB TLR4 ORAI2 TAP2	1.98e-05	615	50	8	MM3641
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	HLA-A HLA-B HLA-C TAP2	2.02e-05	84	50	4	MM1049
Coexpression	KIM_LRRC3B_TARGETS	HLA-A HLA-B HLA-C	2.56e-05	30	50	3	M17363
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING	HLA-A HLA-B HLA-C	2.83e-05	31	50	3	MM3729
Coexpression	TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING	HLA-A HLA-B HLA-C ECH1	2.89e-05	92	50	4	MM3748
Coexpression	ZHONG_PFC_MAJOR_TYPES_ASTROCYTES	SNX3 HLA-A HLA-B HLA-C ADGRB1 LGI1	3.54e-05	326	50	6	M39074
Coexpression	GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN	DNAH17 MDH1B ASIC4 CHRM1 DNAH7	3.94e-05	200	50	5	M7508
Coexpression	PAL_PRMT5_TARGETS_DN	HLA-A HLA-B HLA-C	4.09e-05	35	50	3	MM674
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE	HLA-A HLA-B HLA-C LRP1 ECH1	5.09e-05	211	50	5	MM17081
Coexpression	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN	HLA-A HLA-B	5.32e-05	6	50	2	M7182
Coexpression	TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING	HLA-A HLA-B HLA-C	5.69e-05	39	50	3	MM3758
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING	HLA-A HLA-B HLA-C	5.69e-05	39	50	3	MM3725
Coexpression	HOWLIN_CITED1_TARGETS_1_UP	HLA-A HLA-B HLA-C	6.62e-05	41	50	3	MM710
Coexpression	HU_GENOTOXIC_DAMAGE_4HR	HLA-A HLA-B HLA-C	7.64e-05	43	50	3	MM1204
Coexpression	TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING	HLA-A HLA-B HLA-C	8.19e-05	44	50	3	MM3775
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING	HLA-A HLA-B HLA-C	9.36e-05	46	50	3	MM3712
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING	SNX3 HLA-A HLA-B HLA-C	9.88e-05	126	50	4	MM3711
Coexpression	BAUS_TFF2_TARGETS_UP	HLA-A HLA-B HLA-C	1.13e-04	49	50	3	MM1287
Coexpression	TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING	HLA-A HLA-B HLA-C	1.20e-04	50	50	3	MM3805
Coexpression	TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING	HLA-A HLA-B HLA-C	1.35e-04	52	50	3	MM3808
Coexpression	ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL	SNX3 HLA-A HLA-B HLA-C	1.37e-04	137	50	4	MM16612
Coexpression	TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING	HLA-A HLA-B HLA-C	1.69e-04	56	50	3	MM3852
Coexpression	TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING	HLA-A HLA-B HLA-C TAP2	1.70e-04	145	50	4	MM3744
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING	HLA-A HLA-B HLA-C	1.78e-04	57	50	3	MM3716
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING	HLA-A HLA-B HLA-C	1.97e-04	59	50	3	MM3688
Coexpression	TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING	HLA-A HLA-B HLA-C	1.97e-04	59	50	3	MM3704
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	HLA-A HACD3 NOC2L LRP1 TAP2 SNX29	2.26e-04	457	50	6	M1613
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	HLA-A HLA-B TAP2	2.51e-04	64	50	3	M1887
Coexpression	RUAN_RESPONSE_TO_TNF_UP	HLA-B TAP2	2.74e-04	13	50	2	M1512
Coexpression	GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN	WDR91 KDM3B LRP6 SNX29	2.78e-04	165	50	4	M353
Coexpression	GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP	SNX30 GUSB LRP1 SNX29	3.48e-04	175	50	4	M6684
Coexpression	GAURNIER_PSMD4_TARGETS	HLA-A HLA-B HLA-C	3.70e-04	73	50	3	M11428
Coexpression	TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING	HLA-A HLA-B HLA-C	3.85e-04	74	50	3	MM3796
Coexpression	JAIN_NFKB_SIGNALING	SNX4 NOC2L TAP2	4.00e-04	75	50	3	M17646
Coexpression	TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING	HLA-A HLA-B HLA-C	4.00e-04	75	50	3	MM3759
Coexpression	TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING	HLA-A HLA-B HLA-C	4.00e-04	75	50	3	MM3718
Coexpression	SANA_RESPONSE_TO_IFNG_UP	HLA-A HLA-B HLA-C	4.16e-04	76	50	3	M4551
Coexpression	TABULA_MURIS_SENIS_SPLEEN_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING	HLA-A HLA-B HLA-C ECH1	4.47e-04	187	50	4	MM3833
Coexpression	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	HLA-B TAP2	4.76e-04	17	50	2	M1581
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	WDR91 SNX30 HLA-B HLA-C	4.94e-04	192	50	4	MM752
Coexpression	DURAND_STROMA_NS_UP	HLA-A HLA-B HLA-C ALKBH7	5.13e-04	194	50	4	MM962
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING	HLA-A HLA-B HLA-C	5.20e-04	82	50	3	MM3777
Coexpression	TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING	HLA-A HLA-B HLA-C	5.20e-04	82	50	3	MM3858
Coexpression	GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN	IGBP1 SNX3 DNAH17 ORAI2	5.23e-04	195	50	4	M3327
Coexpression	TABULA_MURIS_SENIS_MAMMARY_GLAND_STROMAL_CELL_AGEING	HLA-A HLA-B HLA-C TSEN34 LRP1	5.27e-04	349	50	5	MM3790
Coexpression	MENON_FETAL_KIDNEY_10_IMMUNE_CELLS	HLA-A HLA-B HLA-C	5.39e-04	83	50	3	M39260
Coexpression	SANA_TNF_SIGNALING_UP	HLA-A HLA-B HLA-C	5.39e-04	83	50	3	M17466
Coexpression	GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN	HLA-A HLA-B HLA-C TAP2	5.44e-04	197	50	4	M9580
Coexpression	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	HLA-A HLA-B HLA-C TAP2	5.44e-04	197	50	4	M7545
Coexpression	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	HLA-A HLA-B HLA-C TAP2	5.54e-04	198	50	4	M8969
Coexpression	DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS	HLA-A HLA-B HLA-C	5.58e-04	84	50	3	M39287
Coexpression	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP	ADRA2B BRD3OS KCNT2 ADGRB3	5.65e-04	199	50	4	M6410
Coexpression	GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	HLA-A HLA-B HLA-C TAP2	5.65e-04	199	50	4	M9568
Coexpression	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	HLA-A HLA-B HLA-C TAP2	5.76e-04	200	50	4	M8967
Coexpression	GSE13306_TREG_VS_TCONV_SPLEEN_UP	SNX30 SNX3 DNAH7 DSCAML1	5.76e-04	200	50	4	M3224
Coexpression	GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN	HLA-A HLA-B HLA-C TAP2	5.76e-04	200	50	4	M9586
Coexpression	GSE42021_TREG_VS_TCONV_PLN_UP	HLA-A HLA-B HLA-C TAP2	5.76e-04	200	50	4	M9572
Coexpression	GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN	HLA-A HLA-B HLA-C TAP2	5.76e-04	200	50	4	M9576
Coexpression	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN	HLA-B HLA-C LRP6 TAP2	5.76e-04	200	50	4	M3638
Coexpression	GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN	HLA-B HLA-C BAZ1B NT5DC3	5.76e-04	200	50	4	M3635
Coexpression	GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN	SNX4 SNX3 HACD3 NUP160	5.76e-04	200	50	4	M3880
Coexpression	GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN	BRD3OS KDM3B ST3GAL4 ORAI2	5.76e-04	200	50	4	M7423
Coexpression	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	LRP6 LRP5	5.97e-04	19	50	2	M12084
Coexpression	MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	HLA-A HLA-B HLA-C	5.98e-04	86	50	3	MM834
Coexpression	TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING	HLA-A HLA-B HLA-C BAZ1B	6.09e-04	203	50	4	MM3795
Coexpression	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	HLA-A HLA-B HLA-C	6.18e-04	87	50	3	MM652
Coexpression	BENPORATH_MYC_MAX_TARGETS	IGBP1 SNX3 CAD HLA-A IL17C TSEN34 BAZ1B	6.35e-04	775	50	7	M17753
Coexpression	CASTELLANO_NRAS_TARGETS_UP	HLA-A HLA-B HLA-C	6.39e-04	88	50	3	MM1087
Coexpression	COATES_MACROPHAGE_M1_VS_M2_DN	HLA-A HLA-B HLA-C	6.83e-04	90	50	3	MM750
Coexpression	TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING	HLA-A HLA-B HLA-C	6.83e-04	90	50	3	MM3756
Coexpression	JIANG_MELANOMA_TRM10_LAMINA_PROPRIA	HLA-A HLA-B HLA-C	7.05e-04	91	50	3	M48974
Coexpression	GAUTAM_EYE_IRIS_CILIARY_BODY_SCHWANN_CELLS	SNX4 HLA-C ADGRB3	7.05e-04	91	50	3	M43622
Coexpression	TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING	HLA-A HLA-B HLA-C	7.05e-04	91	50	3	MM3720
Coexpression	JACKSON_DNMT1_TARGETS_UP	HLA-A HLA-B HLA-C	7.51e-04	93	50	3	MM1185
Coexpression	TABULA_MURIS_SENIS_SPLEEN_NK_CELL_AGEING	HLA-A HLA-B HLA-C	8.24e-04	96	50	3	MM3834
Coexpression	ZHENG_CORD_BLOOD_C8_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_2	HLA-A HLA-B HLA-C	8.49e-04	97	50	3	M39217
Coexpression	TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING	HLA-A HLA-B HLA-C	8.49e-04	97	50	3	MM3789
Coexpression	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	HLA-A HLA-B HLA-C ECH1	8.50e-04	222	50	4	MM1132
Coexpression	MIKKELSEN_MEF_ICP_WITH_H3K27ME3	GIPR HLA-A HLA-B HLA-C	8.64e-04	223	50	4	MM838
Coexpression	ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP	HLA-A HLA-B HLA-C	8.74e-04	98	50	3	MM460
Coexpression	TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING	HLA-A HLA-B HLA-C TSEN34	8.79e-04	224	50	4	MM3767
Coexpression	ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP	HLA-A HLA-B HLA-C	9.27e-04	100	50	3	MM458
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_B_CELL	HLA-A HLA-B HLA-C	9.54e-04	101	50	3	M39045
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	HLA-A HLA-B HLA-C	1.01e-03	103	50	3	MM476
Coexpression	TABULA_MURIS_SENIS_LUNG_ADVENTITIAL_CELL_AGEING	SNX3 HLA-A HLA-B HLA-C	1.03e-03	234	50	4	MM3761
Coexpression	TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING	HLA-A HLA-B HLA-C	1.04e-03	104	50	3	MM3812
Coexpression	TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING	HLA-A HLA-B HLA-C	1.25e-03	111	50	3	MM3831
Coexpression	FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL	SNX3 HLA-A HLA-B HLA-C	1.34e-03	251	50	4	M41709
Coexpression	ZHANG_UTERUS_C9_DENDRITIC_CELL	HLA-A HLA-B HLA-C	1.35e-03	114	50	3	MM16615
Coexpression	TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING	HLA-A HLA-B HLA-C	1.35e-03	114	50	3	MM3799
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_100	HLA-B HLA-C TLR4	1.16e-05	19	50	3	gudmap_kidney_adult_Mesangium_Meis_k2_100
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_k-means-cluster#1_top-relative-expression-ranked_200	HLA-B HLA-C TLR4	4.77e-05	30	50	3	gudmap_kidney_adult_RenCorpuscGlomer_k1_200
CoexpressionAtlas	kidney_adult_GlomCapSys_Tie2_k-means-cluster#4_top-relative-expression-ranked_200	HLA-B HLA-C TLR4	6.38e-05	33	50	3	gudmap_kidney_adult_GlomCapSys_Tie2_k4_200
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#4_top-relative-expression-ranked_500	HLA-B HLA-C TLR4	8.30e-05	36	50	3	gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k4_500
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_200	HLA-B HLA-C TLR4	1.63e-04	45	50	3	gudmap_kidney_adult_Mesangium_Meis_k1_200
ToppCell	URO-Lymphocyte-T_NK-gdT\|URO / Disease, Lineage and Cell Type	GIPR HLA-A HLA-B HLA-C ASIC4	1.42e-06	172	50	5	97b1eb95234639fcaa5ea3c4ba7ec2f4eb929dbf
ToppCell	Sepsis-URO-Lymphocyte-T/NK-gd_T\|URO / Disease, condition lineage and cell class	GIPR HLA-A HLA-B HLA-C ASIC4	2.83e-06	198	50	5	cb584f7754ef4e6d9ec7155022852f2d2676ab4f
ToppCell	Control-PLT_3\|Control / Disease Group and Platelet Clusters	SNX3 HLA-A HLA-B HLA-C	1.85e-05	140	50	4	82ea671f61d55f6896d903c5876b042e2f3385d6
ToppCell	BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)\|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-A HLA-B HLA-C ST3GAL4	2.12e-05	145	50	4	6dd81d53d006fcc206a10969374a11c372f92133
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SV2C ASIC4 NT5DC3 DSCAML1	2.30e-05	148	50	4	5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|390C / Donor, Lineage, Cell class and subclass (all cells)	HLA-A HLA-B HLA-C LGI1	2.43e-05	150	50	4	fdbfc8f743cf848978cf0488493f6df60be53982
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KCNT2 ADGRB3 SV2C RUNX1T1	2.69e-05	154	50	4	b6e982e341c6cfb6ff80a318078fcb10c36d182f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KCNT2 ADGRB3 SV2C RUNX1T1	2.69e-05	154	50	4	d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a
ToppCell	IIF-Lymphocyte-T_NK-CD4_CTL\|IIF / Disease, Lineage and Cell Type	HLA-A HLA-B HLA-C ASIC4	3.05e-05	159	50	4	64e2b57e09bf25b2582f154375bb88cfd02a2521
ToppCell	Brain_organoid-organoid_Velasco_nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	HLA-A HLA-B HLA-C HACD3	3.20e-05	161	50	4	2de213169fe1965ceaea545297228117c81d9909
ToppCell	Bac-SEP-Myeloid-tDC\|Bac-SEP / Disease, Lineage and Cell Type	SNX30 CAD BAZ1B ST3GAL4	3.52e-05	165	50	4	8728f927502e56f2768b4224e9111939d3d7815a
ToppCell	COVID-19_Mild-PLT_3\|COVID-19_Mild / Disease Group and Platelet Clusters	SNX3 HLA-A HLA-B HLA-C	3.96e-05	170	50	4	5ac1252ae3c026a506cfe26e3d119276fe364661
ToppCell	metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	HLA-A HLA-B HLA-C ADGRB3	4.05e-05	171	50	4	d3e1cc1b70256c4d01488d6b6130bbcae99bdeec
ToppCell	normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	HLA-A HLA-B HLA-C LRP5	4.24e-05	173	50	4	1e8a43ff32eab95857c794e0bf4f0b0dba155b4a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNT2 HLA-A HLA-B ASIC4	4.63e-05	177	50	4	85e270b4a0b0da77ffe5987a099e827c02a4adf3
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B HLA-C DNAH17	4.63e-05	177	50	4	fd739ae4a574b72dc26a2a9ff4ef988454298ead
ToppCell	Severe-CD4+_T_activated\|Severe / Disease group and Cell class	HLA-A HLA-B HLA-C RUNX1T1	4.63e-05	177	50	4	a08f170f1143fcdd7d0842a54d9b807a4548f8b7
ToppCell	Severe-CD4+_T_activated\|World / Disease group and Cell class	HLA-A HLA-B HLA-C RUNX1T1	4.73e-05	178	50	4	ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell	Severe-Myeloid-Neutrophil\|Severe / Condition, Lineage, Cell class and cell subclass	HLA-B HLA-C DNAH17 ADGRB1	4.73e-05	178	50	4	454313efe59d71e7327b9758efabf2d893e4a8fd
ToppCell	Severe-Myeloid-Neutrophil-\|Severe / Condition, Lineage, Cell class and cell subclass	HLA-B HLA-C DNAH17 ADGRB1	4.73e-05	178	50	4	8618ae891d62bf70fe860ff7bb2d31868961aa13
ToppCell	IIF-Lymphocyte-T_NK-gdT\|IIF / Disease, Lineage and Cell Type	HTR1D HLA-A HLA-B HLA-C	4.73e-05	178	50	4	3344d1328fd9c570c3a4b2629edec627a442d0e0
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-A HLA-B HLA-C ASIC4	5.05e-05	181	50	4	2f3d04d22d4ac016e61709ea5af3d48885c946c4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNT2 HLA-A HLA-B ASIC4	5.05e-05	181	50	4	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-A HLA-B HLA-C SV2C	5.27e-05	183	50	4	a90ffd9c50caa65f537a2e441e37655e1b622327
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-A HLA-B HLA-C ASIC4	5.27e-05	183	50	4	e3ffef2b57dc5b96466dccc9cd54ba326ccf378a
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-A HLA-B HLA-C SV2C	5.27e-05	183	50	4	13ad20ec140ef5b96fdace3369b5befc0f40bb76
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-A HLA-B HLA-C ASIC4	5.50e-05	185	50	4	487fa382232564f075960899d50afa0edae5d258
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNT2 HLA-A HLA-B HLA-C	5.50e-05	185	50	4	caf4f57f2db9ff72a652c8573e16e7ab180ffc05
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-A HLA-B HLA-C TLR4	5.50e-05	185	50	4	fb84fcf7f51f53489bcb3962fa9cb483e48257ed
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-A HLA-B HLA-C TLR4	5.61e-05	186	50	4	9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WDR91 DNAH7 DSCAML1 SNX29	5.61e-05	186	50	4	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADRA2B KCNT2 ADGRB3 RUNX1T1	5.73e-05	187	50	4	958402fcc78f4c7a7d13d659d776f3817137975f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADRA2B KCNT2 ADGRB3 RUNX1T1	5.73e-05	187	50	4	48bfdb3504c3fefe5db3abac4b790c369680ab4e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WDR91 DNAH7 DSCAML1 SNX29	5.85e-05	188	50	4	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-B HLA-C ST3GAL4	5.85e-05	188	50	4	a29c43a91ed1364a09d5abab6efa51b8061bce74
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-A HLA-B HLA-C SV2C	5.85e-05	188	50	4	0501a8aa850bd2e347020abd1cac4d8075738189
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADRA2B KCNT2 ADGRB3 RUNX1T1	5.97e-05	189	50	4	fac5c291a9a87418bb0878c3d624829bdbf1f428
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNT2 HLA-A HLA-B HLA-C	6.10e-05	190	50	4	494fbab37305a7f92cddec75b291d42282555f5f
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNT2 HLA-A HLA-B HLA-C	6.10e-05	190	50	4	55df73c8b696967a925b1772631f6900eff0fa30
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A HLA-B HLA-C TAP2	6.35e-05	192	50	4	6c089bde63dd5f16a07c5929fb49df600f0b21ab
ToppCell	lymphoid-NK_cell-NK_cell\|World / Lineage, cell class and subclass	HLA-A HLA-B HLA-C ST3GAL4	6.61e-05	194	50	4	7f5adc18e632109694446b8eb1543cbae62dccbe
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C ST3GAL4	6.61e-05	194	50	4	c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e
ToppCell	lymphoid-NK_cell\|World / Lineage, cell class and subclass	HLA-A HLA-B HLA-C ST3GAL4	6.61e-05	194	50	4	4bf5a140be8691e4ec99d7ee15588fd48acd6fb5
ToppCell	3'_v3-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C ST3GAL4	6.74e-05	195	50	4	789149fb52d9d16393e1649358515add60d37f2d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C ST3GAL4	6.74e-05	195	50	4	e756733cf48768bf40058d6cf9039e52f7563133
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TLR4 ADGRB3 MYO15A LGI1	6.74e-05	195	50	4	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TLR4 ADGRB3 MYO15A LGI1	6.74e-05	195	50	4	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	10x5'-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C ST3GAL4	6.74e-05	195	50	4	c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C ST3GAL4	6.88e-05	196	50	4	a3b077e82b1550eb328c84b567b60179001f9a77
ToppCell	10x5'-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	HLA-A HLA-B HLA-C ST3GAL4	6.88e-05	196	50	4	1868ad537b7f04cdad0a0c8282aadbc4f257a722
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-B HLA-C ST3GAL4	7.01e-05	197	50	4	76304df40f87224f8e415677e3ee8fb183fe0c03
ToppCell	ASK452-Immune-Macrophages\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	HLA-A HLA-B HLA-C TLR4	7.01e-05	197	50	4	4cd26ccadfcb0ad63610d06c07cbdb1e463c6af8
ToppCell	3'-Child04-06\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-A HLA-B HLA-C ORAI2	7.01e-05	197	50	4	5da92d069bb32ede5e8f30c5b68c4d0790373467
ToppCell	COVID-19-Heart-Low_count_Fib\|Heart / Disease (COVID-19 only), tissue and cell type	HLA-A HLA-B HLA-C LRP1	7.15e-05	198	50	4	aee3d8757642cd6bbf6dc03e78b3912c6b8e510a
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A HLA-B HLA-C CHRM1	7.15e-05	198	50	4	40c2171e79f578c9116d872c189f953dc61d052d
ToppCell	(0)_NK_cells\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	HLA-A HLA-B HLA-C ST3GAL4	7.15e-05	198	50	4	c91c3ccba118dffb12c0bf8036f51fc76f0e305d
ToppCell	BLOOD--(3)_MNP-(3)_Intermediate_monocytes\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SNX3 HLA-A HLA-B HLA-C	7.15e-05	198	50	4	70c3efd4f6026a6a6065be632160a265d9ecd1e4
ToppCell	390C-Myeloid-Dendritic-cDC1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	SNX3 HLA-B HLA-C TAP2	7.29e-05	199	50	4	60c658e0b709a6c413e9b014a26b453cada85619
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-A HLA-B HLA-C TLR4	7.29e-05	199	50	4	5d976d57872a8a25a11fe8cd53b01aa21a1a519a
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HLA-A HLA-B HLA-C LRP1	7.29e-05	199	50	4	155b03b859157013e9142e9248551369127d9204
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-A HLA-B HLA-C TLR4	7.29e-05	199	50	4	14e09eaa2335d4503de50250eb4258dd5b85b304
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-A HLA-B HLA-C TLR4	7.29e-05	199	50	4	e6715288a586631676722f2323f0d833431161cf
ToppCell	mild_COVID-19-NK\|mild_COVID-19 / disease group, cell group and cell class (v2)	HLA-A HLA-B HLA-C ST3GAL4	7.29e-05	199	50	4	4854f25ee436e1cf577744373ffd87b1221d2b88
ToppCell	Nasal_Brush-Epithelial-Goblet_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	HLA-A HLA-B HLA-C LGI1	7.29e-05	199	50	4	2ac716f887687b5109fb9feced75d5c62646a268
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-A HLA-B HLA-C ST3GAL4	7.29e-05	199	50	4	c3ee60602bdb166a5e67ba1c884dba88b934dfe1
ToppCell	Sepsis-Bac-SEP-Myeloid-tDC\|Bac-SEP / Disease, condition lineage and cell class	SNX30 CAD BAZ1B ST3GAL4	7.29e-05	199	50	4	a2be40d367338d32348a6906c8475aa3b544a0f7
ToppCell	tumor_Lung-Endothelial_cells-Tip-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	HLA-A HLA-B HLA-C TAP2	7.29e-05	199	50	4	80c8641cfd84436eadf2234f1313749e2f73331f
ToppCell	MS-IIF-Lymphocyte-T/NK-CD4+_CTL\|IIF / Disease, condition lineage and cell class	HLA-A HLA-B HLA-C ASIC4	7.29e-05	199	50	4	232f85175f49322eee903dd5e7d8e5a94c751ee0
ToppCell	VE-CD4-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	HLA-A HLA-B HLA-C TAP2	7.29e-05	199	50	4	056a0538ca5e825ae6195b4c76c208708a014533
ToppCell	Nasal_Brush-Epithelial-Goblet_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	HLA-A HLA-B HLA-C LGI1	7.29e-05	199	50	4	aa6f1390283617c7f9aaf91d379024832ea24a9e
ToppCell	10x5'v1-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HLA-A HLA-B HLA-C LRP1	7.44e-05	200	50	4	62e9ca7cf4f49fc8957740acee41a1e530f10541
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-MAIT\|Multiple_Sclerosis / Disease, condition lineage and cell class	HLA-A HLA-B HLA-C ASIC4	7.44e-05	200	50	4	10120f474ac3de10fc8e66158969415bd3f8c1da
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	HLA-A HLA-B HLA-C ASIC4	7.44e-05	200	50	4	bfdafb024a7b20d46837b2e6480dd4929253cd62
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	SNX3 HLA-A HLA-B HLA-C	7.44e-05	200	50	4	4477591efada4007bab1f689017e3ac285267d29
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-A HLA-B HLA-C TLR4	7.44e-05	200	50	4	3007583eaad3a5ae2df010513d3e4df59155123d
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-A HLA-B HLA-C ECH1	7.44e-05	200	50	4	0d3f4097fc07606791feb71e86e0df07231990d7
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	HLA-A HLA-B HLA-C ASIC4	7.44e-05	200	50	4	04954fbe1e2264077228bb582c9a5897a70e6da2
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNT2 ADGRB3 LRP1 RUNX1T1	7.44e-05	200	50	4	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	kidney_cells-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-A HLA-B HLA-C TLR4	7.44e-05	200	50	4	9f1626a7e1bd00977a5c316cafbdf654b52bad94
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Radial_glial-RG\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	SNX3 HLA-A HLA-B HLA-C	7.44e-05	200	50	4	fb7c9c0e4beadad6e41e68f6f889e56650898d22
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Radial_glial\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	SNX3 HLA-A HLA-B HLA-C	7.44e-05	200	50	4	fff209256805a448393c385b79a70c2e2172e49c
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KCNT2 HLA-A HLA-B ASIC4	7.44e-05	200	50	4	913487e065dd580c9cbcbb3c3fc76a8d446f8856
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B HLA-C	2.11e-04	103	50	3	3baaf23a9756be41af3a9b4f720e3ab00f1b674d
ToppCell	(0)_NK/T_cells-(0)_T_CD8\|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	HLA-A HLA-B HLA-C	2.50e-04	109	50	3	73b188278473a3b112d406657680267b17a5b712
ToppCell	moderate-Epithelial-Secretory-diff\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HLA-A HLA-B HLA-C	2.50e-04	109	50	3	f2a07c6a71f6e4587bdc7b85f915bd287028cf17
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GIPR DNAH17 DSCAML1	4.47e-04	133	50	3	f303ab771482281d8793974f9f5279cee09431fe
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-5\|TCGA-Adrenal / Sample_Type by Project: Shred V9	ASIC4 CHRM1 DSCAML1	4.57e-04	134	50	3	d4b175257c47916ed90cdb5c555c2b26530ce8d5
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B HLA-C	5.30e-04	141	50	3	9f26b2a5ccdf8762f16b673e59543b694fbacc10
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CSNK2A2 LRP1 MYO15A	5.41e-04	142	50	3	a05b320cf182b2aaf18df7c40045dc65b659bf20
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CSNK2A2 LRP1 MYO15A	5.41e-04	142	50	3	d52da766e031f7409eb5a7a9fa88f48e14a79d8b
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B HLA-C	5.52e-04	143	50	3	5d5ba2717126a0d4e4464f3604cb282cb977d5b2
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1\|Striatum / BrainAtlas - Mouse McCarroll V32	ADRA2B HTR1D ASIC4	5.87e-04	146	50	3	7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09
ToppCell	Serous\|World / shred by cell class for turbinate	ADRA2B ST3GAL4 CHRM1	6.35e-04	150	50	3	6a326662d58b0f17d6efa8cc28571f4cbbf57c2d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SV2C ASIC4 NT5DC3	6.60e-04	152	50	3	8ff5a178a8f3550d89a003c0858820aab3773386
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-B HLA-C MDH1B	6.72e-04	153	50	3	764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	HLA-A HLA-B HLA-C	6.72e-04	153	50	3	ce7a23c687e9e7d83d244046de19c854caded09b
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GIPR MDH1B DNAH7	6.85e-04	154	50	3	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GIPR MDH1B DNAH7	6.85e-04	154	50	3	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_2\|390C / Donor, Lineage, Cell class and subclass (all cells)	ADRA2B DNAH17 TLR4	6.98e-04	155	50	3	15bacd06cc2b02b13c85bb71c5b758e5ff613e80
ToppCell	metastatic_Brain-T/NK_cells-Naive_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	HLA-A HLA-B HLA-C	7.11e-04	156	50	3	1dcb0b2d1c4b524e692d40e8403dbf7140af19b4
Computational	Genes in the cancer module 293.	HLA-A HLA-B HLA-C	5.69e-06	12	33	3	MODULE_293
Computational	Genes in the cancer module 143.	HLA-A HLA-B HLA-C	9.38e-06	14	33	3	MODULE_143
Computational	Neighborhood of CD48	HLA-A HLA-B HLA-C	1.23e-04	32	33	3	GNF2_CD48
Computational	Neighborhood of INPP5D	HLA-A HLA-B HLA-C	2.99e-04	43	33	3	GNF2_INPP5D
Computational	Neighborhood of HLA-C	HLA-A HLA-B HLA-C	3.90e-04	47	33	3	GNF2_HLA_C
Computational	Neighborhood of PTPN6	HLA-A HLA-B HLA-C	3.90e-04	47	33	3	GNF2_PTPN6
Computational	Genes upregulated in subsets of cells of a given type within various tumors	HLA-A HLA-B HLA-C	4.68e-04	50	33	3	GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	HLA-A HLA-B HLA-C	4.68e-04	50	33	3	GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC
Computational	Genes in the cancer module 27.	ADRA2B HLA-A HLA-B HLA-C LRP1 CHRM1	6.47e-04	355	33	6	MODULE_27
Computational	Neighborhood of CD53	HLA-A HLA-B HLA-C	7.25e-04	58	33	3	GNF2_CD53
Computational	Immune (defense) response.	HLA-A HLA-B HLA-C LRP1	8.87e-04	142	33	4	MODULE_223
Computational	Neighborhood of PTPRC	HLA-A HLA-B HLA-C	1.15e-03	68	33	3	GNF2_PTPRC
Computational	Genes in the cancer module 257.	CAD GLE1 LRP1 LRP5	1.26e-03	156	33	4	MODULE_257
Computational	Neighborhood of STAT6	HLA-A HLA-B HLA-C	1.78e-03	79	33	3	GNF2_STAT6
Drug	Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ADGRB1 LRP1 BAZ1B LRP6 ST3GAL4 ORAI2	2.94e-06	183	50	6	1475_UP
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A	HTR1D DNAH17 ADGRB3 LRP1 SV2C ST3GAL4	3.33e-06	187	50	6	3037_UP
Drug	AC1L1FCN	HLA-A HLA-B HLA-C	4.45e-06	15	50	3	CID000003178
Drug	AC1OCF7F	HTR1D CHRM1	1.42e-05	3	50	2	CID003035836
Drug	1, 3-diallylurea	GUSB ASIC4 RUNX1T1 CHRM1	2.11e-05	74	50	4	CID000074537
Drug	Olanzapine	ADRA2B HTR1D CHRM1	2.22e-05	25	50	3	DB00334
Drug	Ziprasidone	ADRA2B HTR1D CHRM1	2.22e-05	25	50	3	DB00246
Drug	Aripiprazole	ADRA2B HTR1D CHRM1	2.22e-05	25	50	3	DB01238
Drug	D-Au	CAD HLA-A HLA-B HLA-C	2.47e-05	77	50	4	CID000277822
Drug	Clozapine	ADRA2B HTR1D CHRM1	2.50e-05	26	50	3	DB00363
Drug	Quetiapine	ADRA2B HTR1D CHRM1	2.50e-05	26	50	3	DB01224
Drug	T15550	ADRA2B HTR1D CHRM1	2.50e-05	26	50	3	CID000005454
Drug	PA-J	HLA-A HLA-C	2.83e-05	4	50	2	CID000447261
Drug	AC1L1G8Z	ADRA2B HTR1D RUNX1T1	3.88e-05	30	50	3	CID000003581
Drug	PMSD	HLA-A HLA-B	4.71e-05	5	50	2	CID000083890
Drug	pentisomide	GUSB CHRM1	4.71e-05	5	50	2	CID000065847
Drug	brinzolamide	HLA-A HLA-B	4.71e-05	5	50	2	ctd:C111827
Drug	Tb 7	HLA-B GUSB	4.71e-05	5	50	2	CID000454000
Drug	B5-9	HLA-A HLA-B GUSB	4.73e-05	32	50	3	CID003001978
Drug	iloperidone	ADRA2B HTR1D CHRM1	6.76e-05	36	50	3	CID000071360
Drug	Nsc34399	HLA-B CHRM1	7.05e-05	6	50	2	CID000003622
Drug	diflunisal acyl glucuronide	HLA-A GUSB	7.05e-05	6	50	2	CID000173625
Drug	norfenfluramine	ADRA2B HTR1D CHRM1	7.35e-05	37	50	3	CID000015897
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A	WDR91 GLE1 LRP1 BAZ1B ORAI2	7.65e-05	200	50	5	2116_UP
Drug	NSC95090	ADRA2B HTR1D CHRM1	9.30e-05	40	50	3	CID000003251
Drug	BRL 34778	HTR1D CHRM1	9.86e-05	7	50	2	CID000135770
Drug	L-689,660	HTR1D CHRM1	9.86e-05	7	50	2	CID000132658
Drug	Saphris	ADRA2B HTR1D CHRM1	1.00e-04	41	50	3	CID000163091
Drug	secoverine	HTR1D CHRM1	1.31e-04	8	50	2	CID000042470
Drug	S 14489	ADRA2B HTR1D	1.31e-04	8	50	2	CID000182595
Drug	5-OHIP	HTR1D CHRM1	1.31e-04	8	50	2	CID000182581
Drug	NSC186061	ADRA2B HTR1D GUSB CHRM1	1.31e-04	118	50	4	CID000004163
Drug	loxapine	ADRA2B HTR1D CHRM1	1.42e-04	46	50	3	CID000003964
Drug	toxin 7	HTR1D CHRM1	1.68e-04	9	50	2	CID000130462
Drug	3'-hydroxydaidzein	GUSB CSNK2A2	1.68e-04	9	50	2	CID005284648
Drug	procyanidin A2	HLA-A HLA-B	1.68e-04	9	50	2	CID000124025
Drug	catalpol	TLR4 CHRM1	1.68e-04	9	50	2	ctd:C078040
Drug	S 15931	ADRA2B HTR1D	1.68e-04	9	50	2	CID000182596
Drug	DL-tryptophan	HTR1D HLA-A GUSB CHRM1	1.69e-04	126	50	4	CID000001148
Drug	WAY-100635	ADRA2B HTR1D CHRM1	1.71e-04	49	50	3	CID000005684
Drug	zotepine	ADRA2B HTR1D CHRM1	1.71e-04	49	50	3	CID000005736
Drug	AC1Q7BEJ	ADRA2B HTR1D CHRM1	1.82e-04	50	50	3	CID000001224
Drug	sertindole	ADRA2B HTR1D CHRM1	1.82e-04	50	50	3	CID000060149
Drug	S 14671	ADRA2B HTR1D	2.10e-04	10	50	2	CID000131907
Drug	Yohimbine	ADRA2B HTR1D	2.10e-04	10	50	2	DB01392
Drug	estriol glucuronide	HLA-A GUSB	2.10e-04	10	50	2	CID000152963
Drug	AC1L1CCX	HTR1D HLA-B	2.10e-04	10	50	2	CID000001840
Drug	Ergotamine	ADRA2B HTR1D	2.10e-04	10	50	2	DB00696
Drug	methylenedisalicylic acid	HLA-A HLA-B ST3GAL4	2.54e-04	56	50	3	CID000479504
Drug	Galactose	GUSB TLR4 CHRM1	2.54e-04	56	50	3	ctd:D005690
Drug	sodium sulbactam	HLA-A HLA-B HLA-C	2.54e-04	56	50	3	CID000005316
Drug	quinupramine	HTR1D CHRM1	2.57e-04	11	50	2	CID000093154
Drug	siastatin B	HLA-A GUSB	2.57e-04	11	50	2	CID003042898
Drug	quinocarcin	ST3GAL4 MYO15A	2.57e-04	11	50	2	CID000158486
Drug	tramazoline	ADRA2B HTR1D	2.57e-04	11	50	2	CID000005524
Drug	AC1Q6F2A	ADRA2B HTR1D	2.57e-04	11	50	2	CID000060621
Drug	dicyclomine	HTR1D CHRM1	2.57e-04	11	50	2	CID000003042
Drug	LY 171555	ADRA2B HTR1D CHRM1 TAP2	2.67e-04	142	50	4	CID000001257
Drug	Brn 5233018	HLA-A HLA-B RUNX1T1	2.68e-04	57	50	3	CID000128395
Drug	quetiapine	ADRA2B HTR1D CHRM1	2.68e-04	57	50	3	CID000005002
Drug	norclozapine	ADRA2B HTR1D CHRM1	2.68e-04	57	50	3	CID000002820
Drug	tert-butyl acetate	HLA-A HLA-B HLA-C	2.82e-04	58	50	3	CID000010908
Drug	triamterene	HLA-A HLA-B ASIC4	2.82e-04	58	50	3	CID000005546
Drug	bethanidine	ADRA2B CSNK2A2	3.08e-04	12	50	2	CID000002368
Drug	strontium phosphate	HLA-B LRP5	3.08e-04	12	50	2	CID000159737
Drug	AQ-RA 741	HTR1D CHRM1	3.08e-04	12	50	2	CID000129989
Drug	BIBN 99	HTR1D CHRM1	3.08e-04	12	50	2	CID000132712
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-A HLA-B HLA-C	1.50e-07	7	49	3	DOID:0081267 (implicated_via_orthology)
Disease	beta-2 microglobulin measurement	HLA-A HLA-B HLA-C	7.03e-07	11	49	3	EFO_0005197
Disease	complement C4 measurement	HLA-B HLA-C CHRM1 TAP2	1.71e-06	52	49	4	EFO_0004984
Disease	–	HLA-A HLA-B	2.70e-06	2	49	2	608579
Disease	Susceptibility to severe cutaneous adverse reaction	HLA-A HLA-B	2.70e-06	2	49	2	cv:C1840548
Disease	Carbamazepine response	HLA-A HLA-B	2.70e-06	2	49	2	cv:CN077964
Disease	susceptibility to Mycobacterium tuberculosis infection measurement	HLA-A HLA-B HLA-C TAP2	1.29e-05	86	49	4	EFO_0008407
Disease	Drug-Induced Stevens Johnson Syndrome	HLA-A HLA-B HLA-C	1.53e-05	29	49	3	C1274933
Disease	Toxic Epidermal Necrolysis	HLA-A HLA-B HLA-C	1.53e-05	29	49	3	C0014518
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	HLA-A HLA-B HLA-C	1.53e-05	29	49	3	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	HLA-A HLA-B HLA-C	1.53e-05	29	49	3	C3658302
Disease	Stevens-Johnson syndrome (is_implicated_in)	HLA-A HLA-B	1.62e-05	4	49	2	DOID:0050426 (is_implicated_in)
Disease	Stevens-Johnson Syndrome	HLA-A HLA-B HLA-C	1.69e-05	30	49	3	C0038325
Disease	allergic asthma (is_implicated_in)	HLA-B HLA-C	2.69e-05	5	49	2	DOID:9415 (is_implicated_in)
Disease	reactive arthritis (is_implicated_in)	HLA-B TAP2	2.69e-05	5	49	2	DOID:6196 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	GIPR HLA-A HLA-B CSNK2A2 ST3GAL4	3.36e-05	222	49	5	EFO_0008317, EFO_0020943
Disease	allergic contact dermatitis (is_implicated_in)	TLR4 TAP2	4.04e-05	6	49	2	DOID:3042 (is_implicated_in)
Disease	anterior uveitis (is_implicated_in)	HLA-B TLR4	7.52e-05	8	49	2	DOID:1407 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	GIPR HLA-A HLA-B CSNK2A2 ST3GAL4	7.63e-05	264	49	5	EFO_0008317, EFO_0020944
Disease	Schizophrenia	HLA-A HLA-B HLA-C IL17C TLR4 LRP1 CHRM1 TAP2	9.47e-05	883	49	8	C0036341
Disease	Takayasu arteritis	HLA-A HLA-B HLA-C TSEN34	1.08e-04	148	49	4	EFO_1001857
Disease	Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide	HLA-C TAP2	1.47e-04	11	49	2	EFO_0004276, EFO_0004775, EFO_0020996
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	GIPR HLA-A HLA-B HLA-C ST3GAL4	1.55e-04	307	49	5	EFO_0004612, EFO_0020946
Disease	Malignant Glioma	HLA-A HLA-B HLA-C	2.18e-04	70	49	3	C0555198
Disease	mixed gliomas	HLA-A HLA-B HLA-C	2.18e-04	70	49	3	C0259783
Disease	diabetic neuropathy (is_implicated_in)	ADRA2B TLR4	2.43e-04	14	49	2	DOID:9743 (is_implicated_in)
Disease	basal cell carcinoma	HLA-B HLA-C MYO15A DCST1	2.76e-04	189	49	4	EFO_0004193
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	HLA-B HLA-C	2.80e-04	15	49	2	EFO_0801746
Disease	response to thioamide, Drug-induced agranulocytosis	HLA-C TAP2	3.19e-04	16	49	2	EFO_0007633, HP_0012235
Disease	Glioma	HLA-A HLA-B HLA-C	4.14e-04	87	49	3	C0017638
Disease	ankylosing spondylitis (is_implicated_in)	HLA-B TAP2	4.54e-04	19	49	2	DOID:7147 (is_implicated_in)
Disease	angiopoietin-1 receptor measurement	HLA-B ST3GAL4	4.54e-04	19	49	2	EFO_0010600
Disease	cholesteryl ester measurement, intermediate density lipoprotein measurement	HLA-B BAZ1B ST3GAL4	5.19e-04	94	49	3	EFO_0008595, EFO_0010351
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	HLA-A HLA-B BAZ1B ST3GAL4	5.33e-04	225	49	4	EFO_0008317, EFO_0010351
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	GIPR HLA-A HLA-B ST3GAL4	5.33e-04	225	49	4	EFO_0008317, EFO_0020947
Disease	COVID-19 (is_implicated_in)	HLA-B HLA-C	5.56e-04	21	49	2	DOID:0080600 (is_implicated_in)
Disease	Antimigraine preparation use measurement	LRP1 RUNX1T1	5.56e-04	21	49	2	EFO_0009939
Disease	susceptibility to pneumonia measurement	HLA-A HLA-C TAP2	5.69e-04	97	49	3	EFO_0008410
Disease	myocardial infarction (is_implicated_in)	ADRA2B TLR4 LRP1	6.03e-04	99	49	3	DOID:5844 (is_implicated_in)
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	HLA-B BAZ1B ST3GAL4	6.03e-04	99	49	3	EFO_0004574, EFO_0008595
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	GIPR HLA-A HLA-B ST3GAL4	6.68e-04	239	49	4	EFO_0008317, EFO_0020945
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	HLA-B BAZ1B ST3GAL4	6.97e-04	104	49	3	EFO_0008591, EFO_0008595
Disease	Behcet Syndrome	HLA-B TLR4	7.28e-04	24	49	2	C0004943
Disease	Oral ulcer	HLA-A HLA-B TAP2	7.57e-04	107	49	3	HP_0000155
Disease	free cholesterol measurement	HLA-B ST3GAL4 NUP160	8.86e-04	113	49	3	EFO_0008591
Disease	factor VIII measurement, von Willebrand factor measurement	HLA-C ST3GAL4	9.23e-04	27	49	2	EFO_0004629, EFO_0004630
Disease	lymphocyte measurement	HLA-A HLA-B HLA-C	9.80e-04	117	49	3	EFO_0803546
Disease	tuberculosis (is_implicated_in)	HLA-A HLA-B	9.93e-04	28	49	2	DOID:399 (is_implicated_in)
Disease	glycoprotein measurement	HLA-A HLA-B ST3GAL4	1.03e-03	119	49	3	EFO_0004555
Disease	diabetes mellitus (is_implicated_in)	GIPR TLR4	1.07e-03	29	49	2	DOID:9351 (is_implicated_in)
Disease	cervical cancer (is_implicated_in)	HLA-B TAP2	1.14e-03	30	49	2	DOID:4362 (is_implicated_in)
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	HLA-B HLA-C ST3GAL4	1.21e-03	126	49	3	EFO_0004611, EFO_0010351
Disease	esterified cholesterol measurement	HLA-B ST3GAL4 NUP160	1.27e-03	128	49	3	EFO_0008589
Disease	parental longevity	HLA-A HLA-B HLA-C TAP2 SNX29	1.34e-03	494	49	5	EFO_0007796
Disease	sensorineural hearing loss (is_implicated_in)	HLA-B MYO15A	1.38e-03	33	49	2	DOID:10003 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HLA-A HLA-B HLA-C ST3GAL4	1.38e-03	291	49	4	EFO_0008317, EFO_0020946
Disease	Alzheimer's disease (is_implicated_in)	TLR4 LRP1 TAP2	1.39e-03	132	49	3	DOID:10652 (is_implicated_in)
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	HLA-B BAZ1B ST3GAL4	1.54e-03	137	49	3	EFO_0004611, EFO_0008591
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	HLA-B HLA-C BAZ1B ST3GAL4	1.61e-03	303	49	4	EFO_0004612, EFO_0020945
Disease	Behcet's disease (is_implicated_in)	HLA-B TLR4	1.64e-03	36	49	2	DOID:13241 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
YARLRYRDTSLLIWQ	BRD3OS	16	A0A1B0GUI7
VIIYVSVWRYIRSER	ADGRB1	966	O14514
AVVYAALWRYIRSER	ADGRB3	896	O60242
EEYEARLERYSERIW	BAZ1B	36	Q9UIG0
ISLDRYWAVSRALEY	ADRA2B	106	P18089
TAGELYQRWERYRRE	GIPR	31	P48546
RLCYYRDWLLRREDV	GLE1	21	Q53GS7
YRDWVRRSYLELVTS	ORAI2	26	Q96SN7
YWAQRHRELYLRVEL	HACD3	11	Q9P035
REELNYWIRRYSDAE	RUNX1T1	386	Q06455
AYVSRRRYLKLRAEW	MYO15A	1961	Q9UKN7
LDYVTERIYWADARE	LRP1	3196	Q07954
YVYWTDDEVRAIRRA	LRP5	386	O75197
RAYLEGTCVEWLRRY	HLA-C	181	P10321
DERVREYYLLHLQRW	IGBP1	186	P78318
ARISWYLRDIITRYQ	ECH1	136	Q13011
TYQYDLELDRWSLRQ	KBTBD2	551	Q8IY47
SWYLDQTLRKRLYEE	KDM3B	1651	Q7LBC6
LTIDYAKRRLYWTDL	LRP6	796	O75581
ISPWRYRVDTDEDRY	IL17C	106	Q9P0M4
ILDYIYEVSWDRLKR	ASIC4	461	Q96FT7
TADDLWIRTYARLYQ	KCNT2	931	Q6UVM3
RAYLEGECVEWLRRY	HLA-B	181	P01889
TLYYSHWRKLRDREI	NOC2L	616	Q9Y3T9
DDWDRRLCRTYLAEY	DNAH17	4096	Q9UFH2
SWERVSTEVRDYVYR	DCST1	351	Q5T197
VFLTELREATWYELR	DSCAML1	1536	Q8TD84
LLRERYWKIANETRY	GUSB	621	P08236
RLWVHEVLRVYYDRL	DNAH7	2206	Q8WXX0
YYDRLLDNTDRSWLI	DNAH7	2216	Q8WXX0
YYERRWEQSLRALRE	COQ4	236	Q9Y3A0
TLYWRIYRETENRAR	CHRM1	206	P11229
RYWAITDALEYSKRR	HTR1D	136	P28221
RVYAEVNSLRSREYW	CSNK2A2	11	P19784
RAYLDGTCVEWLRRY	HLA-A	181	P04439
DLRKTRVYRYESAIW	MDH1B	321	Q5I0G3
DSLWRRYSEFELLRS	SNX4	101	O95219
DDEWNIYRRYTEFRS	SNX29	686	Q8TEQ0
TWYRRCFVRIRTELY	SV2C	401	Q496J9
YLWERYREAKRSTEE	NT5DC3	56	Q86UY8
VWYSISREDRYIELF	ST3GAL4	21	Q11206
YWRRDLERALYLLVR	TAP2	366	Q03519
DEAWRLLSTYLERYK	NUP160	1286	Q12769
LRRRRYEYDHWDAAI	ALKBH7	56	Q9BT30
EYSVRRRYQDFDWLR	SNX30	126	Q5VWJ9
AHELRYSIYRDLWER	TSEN34	216	Q9BSV6
TVRRRYSDFEWLRSE	SNX3	66	O60493
YSVDRLYELTRIDRW	CAD	821	P27708
RALVYRVWSLEESRY	nan	116	Q6AWC8
YRLLSRNTYLEWEDS	TLR4	786	O00206
LRDYWSYLERRLFSR	WDR91	61	A4D1P6
WYRDTDVEYLEIVRT	LGI1	376	O95970